C3.ai stock plunges after revenue misses estimates by 33%

C3.ai (NYSE:AI) stock plummeted 30% after preliminary first-quarter revenue of $70.2M-$70.4M significantly missed analyst expectations of $104.3M, representing a 33% shortfall and a 19% year-over-year decline. CEO Thomas Siebel attributed the "unacceptable" results to a sales and services organizational restructuring and his health issues, prompting DA Davidson to downgrade the stock to Underperform with a reduced price target. This substantial miss highlights significant operational challenges and raises concerns regarding the company's near-term growth trajectory.

Analysis

C3.ai's stock experienced a 30% collapse following the release of preliminary first-quarter results that demonstrated severe operational and sales execution failures. The company's reported preliminary revenue of approximately $70.3 million fell drastically short of analyst expectations of $104.3 million, a 33% miss against guidance and a significant 19% year-over-year decline. This revenue shortfall translated into substantial losses, with a GAAP operating loss of around $124.8 million. Management, led by CEO Thomas Siebel, attributed the "unacceptable" performance to a disruptive restructuring of its sales organization and the CEO's own health issues, which raises concerns about key-person risk and the stability of its go-to-market strategy. The market's negative sentiment was validated by a DA Davidson downgrade from Neutral to Underperform, accompanied by a price target slash from $25 to $13. While the company retains a cash position of $711.9 million, the magnitude of the miss and the ongoing leadership overhaul create significant uncertainty ahead of the full financial results and revised fiscal 2026 guidance scheduled for September 3, 2025.

Key Decisions for Investors

• Investors should recognize the significant execution risk highlighted by the 33% revenue miss and internal restructuring, warranting extreme caution for any long positions.
• The upcoming September 3rd release of full results and updated fiscal 2026 guidance is a critical catalyst; any investment decision should be deferred until there is clarity on the company's new growth trajectory and cash burn rate.
• The analyst downgrade to Underperform with a $13 price target suggests substantial further downside, and investors should consider the stock highly speculative until a tangible turnaround in sales performance is evident.
• Monitor the effectiveness of the newly appointed executive team, as their ability to stabilize the sales organization will be paramount to restoring investor confidence.